Schizophrenia.com

FDA Approves Deutetrabenazine for Treatment of Tardive Dyskinesia

anon79999497 August 31, 2017, 8:41pm 1

5 Likes

Topic		Replies	Views	Activity
Effects of Long-Term Deutetrabenazine Treatment in Patients with Tardive Dyskinesia and Underlying Psychiatric or Mood Disorders News	0	210	April 28, 2022
Unique and overlapping mechanisms of valbenazine, deutetrabenazine, and vitamin E for tardive dyskinesia News	1	39	April 24, 2025
Antipsychotic Dose Reduction Increases Mental Health-Related and All-Cause Hospitalizations News	0	359	October 12, 2018
Two New Drugs for Tardive Dyskinesia Hit the Market Medications	5	877	January 4, 2018
Biotech Company - Neurocrine - FDA approves first drug for tardive dyskinesia News	3	1108	April 12, 2017